BOSTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Corium, LLC (“Corium”), a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and ...
Corium, Inc. announced that its poster, “Serdexmethylphenidate/d-Methylphenidate Capsules for Children With ADHD: Effects on SKAMP-C Evaluated Over 13 Hours in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback